Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) criteria are the gold standard for risk‐stratifying patients with metastatic renal cell cancer (mRCC). We developed a novel risk scoring system for patients with mRCC treated with immune checkpoint inhibitors (I...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Martini, Dylan J., Liu, Yuan, Shabto, Julie M., Carthon, Bradley C., Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
Genitourinary Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066702/
https://ncbi.nlm.nih.gov/pubmed/32162798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0578
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi